EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Computational Design and In Silico Immune Profiling of a Broad-Coverage Circular mRNA Vaccine Candidate against SARS-CoV-2

Muhammad Muntazir Mehdi, Shuzhen Tan, Munsif Ali Jatoi, Haiyun Liu, Abdul Aziz Khan, Muhammad Tariq Navid, Lingbo Chen, Sami Ullah, Yaozhong Ding

In Silico Research in Biomedicine · 2026-11 · 100719

DOI: 10.1016/j.insi.2026.100719 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Silico Research in Biomedicine, 2026-11. Verfasst von Muhammad Muntazir Mehdi und 8 weiteren Autor:innen. Die Arbeit nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The continued emergence of new SARS-CoV-2 variants with the potential to spread worldwide and the ability to evade natural and vaccine-induced immune responses have raised serious concerns about the protective immunity against SARS-CoV-2 infection. Therefore, the newly improved vaccines with high efficacy, increased durability and broadened long-term immunity are urgently needed. We hypothesize that identifying immunogenic and highly conserved B-cell and T- cell epitopes of spike and nucleocapsid proteins and developing a multi-epitope vaccine using circular mRNA technology could be a potential solution to combat these new VOCs by inducing robust cellular and humoral immunity. Hence, in this research work, we have designed a broad spectrum circular mRNA vaccine comprising highly conserved B-cell and T-cell epitopes of the spike and nucleocapsid proteins. First, B- and T-cells epitopes were predicted and then non-toxic, non-allergic B-cell and highly conserved HTL and CTL T-cell epitopes were selected on the basis of IC50 value and linked together using linkers followed by structural analysis of the final antigen and mRNA construct. Structural analysis showed that both antigen and mRNA were highly stable and molecular docking analysis revealed the potential stable interactions between the vaccine and TLR3 & TLR4. C-ImmSim Server predicted robust immune responses and while population coverage analysis estimated theoretical coverage of 92.34 % of the world population. Taken together, this vaccine candidate is predicted to be highly immunogenic, structurally stable, non-toxic, and non-allergic with the potential to elicit robust in silico immune responses and a broad theoretical applicability across diverse human populations.

Zitieren

APA

Mehdi, M. M., Tan, S., Jatoi, M. A., Liu, H., Khan, A. A., Navid, M. T., Chen, L., Ullah, S., & Ding, Y. (2026). Computational Design and In Silico Immune Profiling of a Broad-Coverage Circular mRNA Vaccine Candidate against SARS-CoV-2. In Silico Research in Biomedicine, 100719. https://doi.org/10.1016/j.insi.2026.100719

Vancouver

Mehdi MM, Tan S, Jatoi MA, Liu H, Khan AA, Navid MT, et al. Computational Design and In Silico Immune Profiling of a Broad-Coverage Circular mRNA Vaccine Candidate against SARS-CoV-2. In Silico Research in Biomedicine. 2026:100719. doi:10.1016/j.insi.2026.100719

BibTeX
@article{Mehdi2026,
  author = {Mehdi, Muhammad Muntazir and Tan, Shuzhen and Jatoi, Munsif Ali and Liu, Haiyun and Khan, Abdul Aziz and Navid, Muhammad Tariq and Chen, Lingbo and Ullah, Sami and Ding, Yaozhong},
  title = {Computational Design and In Silico Immune Profiling of a Broad-Coverage Circular mRNA Vaccine Candidate against SARS-CoV-2},
  journal = {In Silico Research in Biomedicine},
  year = {2026},
  pages = {100719},
  doi = {10.1016/j.insi.2026.100719}
}
Kostenlos starten →